li>Represent Global Patient Safety at key governance and external forums (e.g., DRC, eCRC, SARB, FSIRB, DSMB/DMC, MARC, CPT, GPT, Advisory Boards) in partnership with the Global Safety Head; lead responses to complex technical safety issues.
In this role, you are accountable to the Global Safety Head, Cell Therapy, for the end‑to‑end safety strategy, delivery, and oversight of AZD0120 Multiple Myeloma program, and potentially other assets, across pre‑clinical, clinical, and post‑marketing.